WCN26-3472 RISK FACTORS AND CLINICAL OUTCOMES OF HYPONATREMIA IN COVID-19 PATIENTS ADMITTED AT A TERTIARY HOSPITAL FROM JANUARY 1, 2021 TO DECEMBER 31, 2021: A CASE-CONTROL STUDY

Read full text Summarise with VIRAT
Authors: JILL THERESE AU, Brian Michael I. Cabral
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Systemic inflammation has been associated with severe COVID-19 disease and mortality. Studies have found that hyponatremia in COVID-19 can result from inflammation-induced non-osmotic release of antidiuretic hormone. This study was conducted to identify the risk factors associated with hyponatremia (Na < 135mmol/L) in COVID-19 patients. The clinical outcomes of COVID-19 patients with and without hyponatremia were also compared.

Fields of Study & Subjects

Electrolyte and hormonal disorders COVID-19 Clinical Research Studies Intensive Care Unit Cognitive Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104559–104559
Publication date
25 March 2026
Language
EN